My watch list
my.bionity.com  
Login  

635 Current news from israel

rss
matching the following criteria

Mymetics-Led Consortium Awarded €8.4 Million for Development of Thermo Stable and Cold-Chain Independent Vaccines

24-Apr-2015

Mymetics Corporation announced that its subsidiary Mymetics BV in the Netherlands is leading a consortium that has been selected to receive project grants with a total value of €8.4 million. A total of €5.3 million is funded as part of Horizon 2020, the European Union research and innovation ...

more

Santhera's Positive Phase III Trial (DELOS) in Patients with Duchenne Muscular Dystrophy

24-Apr-2015

Santhera Pharmaceuticals announced that the full results of the double-blind placebo-controlled Phase III trial (DELOS) demonstrating efficacy and safety of Raxone®/Catena® (INN: idebenone) in patients with DMD have been published in The Lancet. The results of the DELOS trial demonstrated that ...

more

Evidence grows that melanoma drugs benefit some lung cancer patients

Many patients with BRAF-mutant cancers benefit from treatment with BRAF inhibitors, European researchers report at ELCC

22-Apr-2015

A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland.Dr. Oliver Gautschi, a ...

more

DNA blood test detects lung cancer mutations

Circulating tumour DNA in blood a valid option for EGFR testing in patients who do not have accessible tumour tissue, study shows

21-Apr-2015

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Geneva, ...

more

Smokers underestimate risks of a few cigarettes

Survey shows that many live in ‘denial’ of the real risks of smoking even a small number of cigarettes a day

20-Apr-2015

Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day, despite decades of public health campaigning, French researchers have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland. The results demonstrate powerfully ...

more

Sobi receives orphan drug designation for Elocta in Switzerland

17-Apr-2015

Swedish Orphan Biovitrum AB has received orphan drug designation in Switzerland for its long acting haemophilia drug candidate Elocta (rFVIIIFc) developed for the treatment of haemophilia A. An orphan drug designation is to encourage the development of medicines for rare diseases and provides ...

more

MyCartis Announces Appointment of Dr. Jan Groen to its Board of Directors

13-Apr-2015

MyCartis NV announced that Dr. Jan Groen, an accomplished diagnostics executive, was elected to the company’s Board of Directors. Dr. Groen currently serves as president and chief executive officer of MDxHealth, a multinational healthcare company that provides actionable epigenetic information to ...

more

Santhera receives FDA Fast Track Designation for Raxone/Catena (idebenone)

10-Apr-2015

Santhera Pharmaceuticals announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Santhera's Raxone®/Catena® (idebenone) for the treatment of Duchenne Muscular Dystrophy (DMD). FDA's Fast Track program facilitates the development and review of important ...

more

Merck Serono and Medicines for Malaria Venture Sign Agreement to Develop Potential Antimalarial Therapy

08-Apr-2015

Merck Serono, the biopharmaceutical business of Merck, and Medicines for Malaria Venture (MMV) announced that an agreement has been signed for Merck Serono to obtain the rights to the investigational antimalarial compound DDD107498 from MMV. This agreement underscores the commitment of Merck ...

more

Evolva and Valent BioSciences to co-develop agricultural bioactives

27-Mar-2015

Evolva and Valent BioSciences Corporation (VBC), a subsidiary of Sumitomo Chemical Company, have signed an exclusive agreement to co-develop and commercialise a class of high-value active ingredients for use as next-generation agricultural bioactives. For competitive reasons, the ingredients are ...

more

Page 1 From 64
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE